·PIB·15 marks·250–350 words

How can AI-enabled traditional medicine research enhance India's global soft power in health diplomacy?

In this answer
  1. Building scientific credibility
  2. Agenda-setting in global institutions
  3. Exportable digital public goods
  4. The trust condition

Soft power in health diplomacy flows from credible knowledge others wish to adopt. India's positioning of AI-enabled Ayush research — recognised in WHO's technical brief Mapping the Application of Artificial Intelligence in Traditional Medicine [1] — converts a civilisational asset into an exportable, evidence-backed public good.

Building scientific credibility

  • The chief barrier to global acceptance of traditional medicine is the evidence deficit; AI addresses it directly. WHO's brief cites India's Ayurgenomics, Prakriti-based predictive diagnostics, and platforms like SAHI, NAMASTE and the Ayush Research Portal [1].
  • The IndiaAI (MeitY)–Ministry of Ayush MoU onboards anonymised Ayush datasets and models onto AIKosh, India's sovereign AI repository, and opens IndiaAI compute to Ayush researchers [2] — the infrastructure for reproducible, publishable evidence.

Agenda-setting in global institutions

  • India's proposal seeded WHO's first-ever roadmap on AI in traditional medicine [1] — norm-shaping, not merely participation.
  • AIIA, New Delhi hosted the WHO Global Traditional Medicine Centre's technical consultation (September 2024) with 60 participants from 15 countries, mandating a WHO–WIPO guidance on AI and intellectual property and a global traditional-medicine repository [3].

Exportable digital public goods

  • The BHASHINI partnership extends Ayush Grid portals and AI tools into all 22 Eighth Schedule languages, with domain-specific multilingual terminology [4] — a low-cost template readily transferable to Global South partners facing similar language and access constraints.

The trust condition

  • Influence survives only if the tools withstand scrutiny. WHO asks governments to assign a regulatory agency to approve health AI and mandate independent third-party post-release audits, warning of automation bias in citizen-facing tools [5]. India has signed partnerships but not yet named such a gate.

Thus AI transforms Ayush from heritage claim to validated, shareable capability — the surest route to influence. Pairing the current deployment push with a published validation and audit standard would let India export rules alongside tools, deepening health diplomacy consistent with SDG-3's universal health goal.

Sources

  1. 1India's Ayush Innovations Featured in WHO's Landmark Brief on AI in Traditional Medicine, PIBWHO technical brief; Ayurgenomics, SAHI, NAMASTE, Ayush Research Portal; India-proposed WHO roadmap
  2. 2IndiaAI and Ministry of AYUSH Sign MoU to Accelerate AI Innovation in Traditional Healthcare, PIBAIKosh onboarding of Ayush datasets; IndiaAI Compute access
  3. 3Global Experts Convene at AIIA to Explore AI Integration in advancing Traditional Medicine, PIB60 participants from 15 countries; WHO–WIPO guidance and global repository mandate
  4. 4Ministry of Ayush Signs MoU with Digital India BHASHINI Division, PIBAyush Grid in 22 scheduled languages; domain-specific multilingual terminology
  5. 5WHO releases AI ethics and governance guidance for large multi-modal modelsregulatory approval agency, mandatory third-party post-release audits, automation bias

More from this note